clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
New Approach for Microbiome Biomarker Discovery in Colon Cancer Gets Results
News & Features
PRMT5 Inhibition Stops Growth in Resistant Breast Cancer
News & Features
USPSTF Lowers Recommended Breast Screening Age to 40
News & Features
mRNA Cancer Vaccine Reprograms Immune System to Tackle Glioblastoma
News & Features
“Major Gaps” in Cancer Screening Rates at Federally Qualified Health Centers
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Antidiabetic agents
News & Features
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Malorye Branca
-
April 22, 2024
0
News & Features
Weight Loss Drugs Linked to Lower Rate of Multiple Sclerosis
Malorye Branca
-
April 16, 2024
0
News & Features
Scandinavian Study Clears GLP-1 Agonists of Thyroid Cancer Risk
Alisa Kirkin
-
April 11, 2024
0
News & Features
Weekly Semaglutide Injection Reduces Liver Disease Severity in People with HIV
Chris Anderson
-
March 6, 2024
0
News & Features
Semaglutide Cuts Death by Quarter among Diabetics with Kidney Disease
Malorye Branca
-
March 5, 2024
0
News & Features
Bone Formation Protein Protective of Cardiovascular Health in Patients with Type 2 Diabetes
Chris Anderson
-
January 29, 2024
0
News & Features
Insulin Delivered via Nano-Carriers May Pave Way for Oral Diabetes Treatment
Chris Anderson
-
January 22, 2024
0
News & Features
Kidney Disease Drug Candidate Shows Broad Inhibition of Damaging Hormone
Chris Anderson
-
December 18, 2023
0
News & Features
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
Chris Anderson
-
December 8, 2023
0
News & Features
In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss
Malorye Branca
-
November 9, 2023
0
1
2
3
Page 1 of 3
Related Content
Enlaza Nets $100M to Advance Covalent Biologics Platform
hC Bioscience Will Target Hemophilia A with Modified tRNA Therapy
Weight Loss Drugs Linked to Lower Rate of Multiple Sclerosis
Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes
Inside Precision Medicine
![Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1628-768x794.jpeg "Metsera Launches with $290M to Develop Next Generation Weight Loss Products")
